Elena's decision to check FDA clearance before she downloaded anything was not a paranoid detour through red tape. It was a quiet act of self-respect, a refusal to spend her dwindling reserves of trust on a product whose claims she could not verify. What she discovered, and what most of us will discover when we do the same small piece of work, is that the distance between "available on the App Store" and "reviewed by a regulatory body" is far wider than the marketing language ever admits.
Why Marketing Language Is Not Medical Review
An app store listing is not a clinical trial. The platforms that host ADHD apps run on a different logic than the FDA does. Apple's App Store and Google Play evaluate security, malware, and basic content policies; they do not assess whether an app treats, diagnoses, or manages a medical condition. A developer can release an attention-training game with a polished interface and a confident voice, and it can sit beside genuinely cleared medical software without anyone on the platform side asking a clinical question.
This is why we have to become informed consumers, even when we would rather not. The phrase "evidence-based" appears on roughly two-thirds of mental health app websites, often without a citation attached. "Clinically validated" sometimes means a small pilot study of twenty undergraduates; sometimes it means nothing verifiable at all. We are not being told a lie, exactly; we are being asked to do the verification that the marketplace has chosen to leave to us.
The app store is not a regulator; it is a storefront. The verification work belongs to us.
Medical Devices Versus General Wellness: Where the Line Sits
The structural reality framing this whole question is simpler than it looks. The FDA divides digital health products into categories, and the category an app falls into determines everything about the rigor applied before it reaches you.
A product classified as a medical device has gone through a formal premarket review. The FDA has examined the manufacturer's evidence and made a judgment about safety and effectiveness for a specific intended use. Software that diagnoses, treats, cures, mitigates, or prevents disease sits in this category, and it carries the regulatory weight you would expect.
A product classified as general wellness has not. Wellness products are software with low risk that targets general health or healthy lifestyle goals, and they can make claims about relaxation, motivation, or memory training, as long as those claims do not specifically target a disease. They do not need FDA clearance. They do not need to demonstrate clinical efficacy. They are not required to publish their evidence.
When we pick up an ADHD app, we are picking up one of these two things, and the difference matters enormously. Some ADHD apps are genuinely regulated digital therapeutics. Many more are wellness tools that borrow medical language without medical accountability. The first step of verification is simply to know which kind of app we are looking at.
How to Check: A Step-by-Step Walk Through the FDA Databases
Elena's method was methodical but not complicated. She treated the FDA's own public databases as the source of truth, and she let the database tell her whether the manufacturer had actually shown up for regulatory review. We can do the same thing in roughly the time it takes to brew a cup of coffee, and use those minutes to anchor a real, evidence-based decision.
| Step | Where to Look | What to Search | What It Tells You |
|---|---|---|---|
| 1 | FDA 510(k) Premarket Notification database | Manufacturer's legal name or product trade name | Whether the device has been cleared as substantially equivalent to a predicate device |
| 2 | FDA De Novo database | The same identifiers | Whether the device was authorized as a novel low-to-moderate-risk device with no predicate |
| 3 | FDA Premarket Approval (PMA) database | The same identifiers | Whether the device went through the most rigorous review, which is rare for digital therapeutics |
| 4 | Manufacturer's own site, "Regulatory" or "Science" page | The product name | Whether the company itself cites a clearance number, and what it claims |
Begin at the FDA's public data portal. Type the manufacturer's name first, then the product name if needed. The database will return a result, and that result will fall into one of three categories. There will be a clearance record, the affirmative answer we are looking for. There will be a De Novo classification record, signaling authorization for a novel device. Or there will be nothing, which is itself a piece of information, and an important one.
A small note on naming. Manufacturers often have a corporate parent and a product brand, and the two may not match. Akili Interactive, for instance, makes EndeavorRx, the first game-based digital therapeutic authorized by the FDA for ADHD in children. Searching for "EndeavorRx" and "Akili" should both lead to the same record, but it helps to try both, because the company name on a regulatory filing is not always the name on a landing page.
Clearance Versus Approval: The Words That Matter
We need to slow down here, because the vocabulary of FDA pathways is precise, and that precision protects us.
FDA clearance (510(k)) means the manufacturer has demonstrated that the device is substantially equivalent to another legally marketed device. It is a real and meaningful review, but it is not the most rigorous pathway. Most cleared digital therapeutics land here.
De Novo classification is the pathway for novel devices that are low to moderate risk and have no existing predicate. EndeavorRx was authorized through De Novo in 2020, an inflection point for digital therapeutics in mental health and a real signal that software-based care can clear the regulatory bar.
FDA approval (PMA) is reserved for high-risk devices and requires the most extensive evidence, including clinical trials. It is uncommon in digital therapeutics for ADHD, and it is not the standard we should expect.
The phrase "FDA approved" gets used loosely. Many apps that are not approved at all describe themselves with language that hovers near approval. The precise term is "FDA cleared" for 510(k) and De Novo devices. When we see marketing language sliding between these words, we have permission to slow down and ask which one the company actually means.
Software as a Medical Device, and Why the SaMD Distinction Matters
There is a category inside the FDA's framework called Software as a Medical Device, abbreviated SaMD, that helps us understand what is and is not being reviewed. SaMD refers to software intended to be used for one or more medical purposes without being part of a hardware medical device. Digital therapeutics for ADHD are typically classified as SaMD, and the SaMD framework establishes risk categories that determine how much clinical evidence is required before authorization.
This is the layer that separates a serious digital therapeutic from a productivity app with a meditation track. A SaMD-classified ADHD product has been evaluated for the specific claim it makes. A wellness app has not. The distinction is regulatory on paper, but it translates into a meaningful difference in the rigor of the evidence behind the product, and in the claims a company can legally make about it.
If a product is making a medical claim, the law expects evidence. The SaMD framework is where that expectation lives.
Red Flags Worth Naming Out Loud
We have walked through what verified apps look like. Now we should walk through what the absence of verification looks like, because marketing language often tries to obscure the gap. Watch for these signals.
1. The app describes itself as "clinically validated" but does not link to a specific study, a registry number, or a peer-reviewed publication.
2. The app uses the phrase "FDA approved" when its actual status is general wellness, or no FDA status at all.
3. The app's "Research" or "Science" page features testimonials and cherry-picked findings rather than full study citations.
4. The app promises diagnostic capability. Diagnostic claims from a non-cleared consumer app are a serious red flag, not a feature.
5. The company is unresponsive when we ask, by email, for a 510(k) or De Novo number.
6. The app markets itself for multiple unrelated conditions without differentiating evidence for each.
7. The app's website emphasizes celebrity endorsements, influencer testimonials, or before-and-after personality narratives over clinical data.
None of these signals are proof of harm, but each one is a reason to slow down. The pattern matters more than any single flag, and naming the pattern out loud is itself a form of protection.
An Anchored Way Forward
Here is the part of the work that has nothing to do with databases. Verification protects us from being misled, but it does not protect us from the deeper question underneath the search, which is whether we are ready to trust anything at all. After years of half-finished focus experiments and discarded habit trackers, our skepticism can harden into a posture that keeps us from any new tool, and we end up doing nothing because doing something feels unsafe.
Elena's small act of checking the database was, in the end, a way of rebuilding that trust, one verifiable claim at a time. She did not have to trust the marketing. She did not have to trust the aesthetic. She had to trust the public record, and the public record is something we can all learn to read.
The same principle of grounded verification extends to other corners of self-care, including the way we choose to move our bodies. If you are a mother navigating ADHD and looking for a fitness resource that takes evidence seriously, this thoughtful guide to fitness for moms takes a similarly grounded approach to wellness, and the same instinct for verification serves us well there.
So here is the micro-habit worth keeping, the one anchored in this article and meant to outlive it. The next time you consider an ADHD app, give yourself fifteen minutes before you download it. Open the FDA database, search the manufacturer's name, and let the result make the decision alongside you. If the record exists, you have a real starting point. If it does not, you have a different kind of starting point, and either one is more honest than the splash screen ever promised.
We do not have to solve our attention in a single decision. We have to keep making small, verifiable ones, and trust that the cumulative weight of those choices is what carries us forward.
